Author: Staff

NeuroMetrix has received FDA 510(k) approval for the SENSUS Pain Management Device intended for use as a transcutaneous electrical nerve stimulator for symptomatic relief and management of chronic intractable pain.

There are several different legal issues that face the surgery center industry. This article briefly outlines 11 core legal risk areas.

This article is written by Scott Becker, David Pivnick and Lindzi Timberlake of McGuireWoods.This article discusses 12 ideas and tactics that are critical to ASC success today and over the next 24 to 36 months. To stay effective and profitable,…

This article was written by Dick Pepper, a medical marketing specialist who blogs at VoxMD.com and can be reached at dick .pepper@voxmd.com.Minimally Invasive Spine Surgery has been getting a lot of well-deserved press lately, and we hear that more and more people…

Best practices and evidence-based care are becoming increasingly important for hospitals as they work to improve quality and reduce costs. Basing clinical care and financial decisions on data will be crucial for hospitals to ensure they meet goals in every…

James Andrews, MD, of Andrews Institute for Orthopaedics & Sports Medicine in Gulf Breeze, Fla., will perform elbow surgery on Blue Jays pitcher Drew Hutchison, according to a Toronto Sun report.

MiMedx Group raised more than $4.9 million through the exercise of callable warrants issued in conjunction with the October 2010 private placement.

Johnson & Johnson's acquisition of Synthes tops the list of the medical device industry's largest transaction, according to Mass Device analysis.

Zimmer Holdings and Tokyo-based Seikagaku have won a patent infringement lawsuit filed by Sanofi, according to a Bloomberg Businessweek report.

Central Phoenix Surgical Center has received approval from various regulatory bodies to add Progenitor Cell Therapy to its list of interventional pain services.